Liver Disease
Interleukin 22 is a liver cell survival factor in murine liver injury models
Published in Cancer Weekly, July 6th, 2004
According to published research from the United States, "the central role of T cell activation in hepatocellular injury has been well documented. In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear."
"IL-22 messenger RNA and protein expression are significantly elevated in T cell-mediated hepatitis induced by concanavalin A (ConA) but are less extensively elevated in the carbon...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-07-06)
More Articles from Cancer Weekly
- Antioxidants
Ascorbic acid makes cancer cells insensitive to chemotherapy - Chemotherapy
Cell density affects the cytotoxicity of daunorubicin and cytosine arabinoside - Hematology
Hematopoietic growth factors manage the effects of non-Hodgkin lymphoma therapy - Oncology
Thrombospondin 1 bears fragments that counteract its antiangiogenic potential - Radiotherapy
HIM-prostate brachytherapy performs well in the community setting - Abdominal Surgery
Surgical interdisciplinarity is needed for abdominal surgery - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
